When evaluating the effect of DPP4 inhibitors on cognitive impairment in T2D, we selected the Montreal Score (MoCA) or the MMSE as an indicator to improve cognitive impairment [15]. The gene discussed is DPP4; the disease is type 2 diabetes mellitus.